4.7 Article

Spi-B inhibits human plasma cell differentiation by repressing BLIMP1 and XBP-1 expression

Journal

BLOOD
Volume 112, Issue 5, Pages 1804-1812

Publisher

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2008-01-136440

Keywords

-

Categories

Funding

  1. National Institutes of Health [R01-AI52002]
  2. National Institute of Allergy and Infectious Diseases, National Institutes of Health [F32-AI0638-46]

Ask authors/readers for more resources

The terminal differentiation of B cells into antibody-secreting plasma cells is tightly regulated by a complex network of transcription factors. Here we evaluated the role of the Ets factor Spi-B during terminal differentiation of human B cells. All mature tonsil and peripheral blood B-cell subsets expressed Spi-B, with the exception of plasma cells. Overexpression of Spi-B in CD19(+) B cells inhibited, similar to the known inhibitor BCL-6, the expression of plasma cell-associated surface markers and transcription factors as well as immunoglobulin production, ie, in vitro plasma cell differentiation. The arrest in B-cell differentiation enforced by Spi-B was independent of the transactivation domain, but dependent on the Ets-domain. By chromatin immunoprecipitation and assays using an inducible Spi-B construct BLIMP1 and XBP-1 were identified as direct target genes of Spi-B mediated repression. We propose a novel role for Spi-B in maintenance of germinal center and memory B cells by direct repression of major plasma cell factors and thereby plasma cell differentiation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available